# Thymol on Netrin-1 on Obese Patients

> **NCT05427721** · PHASE2 · UNKNOWN · sponsor: **Centro Universitario de Ciencias de la Salud, Mexico** · enrollment: 30 (estimated)

## Conditions studied

- Inflammatory Response
- Obesity

## Interventions

- **DRUG:** Thymol

## Key facts

- **NCT ID:** NCT05427721
- **Lead sponsor:** Centro Universitario de Ciencias de la Salud, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2022-12-15
- **Final completion:** 2022-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05427721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05427721, "Thymol on Netrin-1 on Obese Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05427721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*